Insider · CIK 0001279191
Gerald T Proehl
directorceopresidentchairofficerowner
Files at TENX (TENAX THERAPEUTICS, INC.), DRMA (Dermata Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | DRMA Dermata Therapeutics, Inc. | AGrant or award Common Stockindirect: By Proehl Investment Ventures LLC | +787,402 | - | - | 799,508 | Jan 23, 2025 |
| Jan 21, 2025 | DRMA Dermata Therapeutics, Inc. | AGrant or award Warrant (Right to Buy)derivativeindirect: By Proehl Investment Ventures LLC | +787,402 | - | - | 787,402 | Jan 23, 2025 |
| Jan 13, 2025 | DRMA Dermata Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jan 14, 2025 |
| Dec 10, 2024 | TENX TENAX THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Dec 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.